The QC reader profile is younger than anywhere else on this site: university athletes around Diliman and Katipunan, martial arts and team-sport players, and a large group of people in their twenties working desk jobs in Eastwood who train seriously on the side. They are price-sensitive in a way that is completely rational, and they compensate for it by doing more reading than the rest of the metro combined.
That reading is where the honest framing has to land. BPC-157 has been studied in animal models for tendon and ligament work, with the rat Achilles detachment experiments and the tendon outgrowth and cell migration work among the most cited, plus a body of gastrointestinal research. That is preclinical evidence. It is not a human treatment for a torn anything, nothing here is approved for human therapeutic use in the Philippines, and a compound with no human trial programme is a poor place to put money you do not have.
I say that to QC readers more directly than to any other district, because they are the ones for whom ₱2,650 is a real decision rather than a rounding error. The compound is genuinely one of the cheaper research peptides on this market. It is still not free, and the imaging that would tell you what you are working around costs several times more than the vial does.